Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.

MLA

Uttarkar, Sagar, et al. “Targeting Acute Myeloid Leukemia with a Small Molecule Inhibitor of the Myb/P300 Interaction.” Blood, vol. 127, no. 9, Mar. 2016, pp. 1173–82. EBSCOhost, https://doi.org/10.1182/blood-2015-09-668632.

APA

Uttarkar, S., Dassé, E., Coulibaly, A., Steinmann, S., Jakobs, A., Schomburg, C., Trentmann, A., Jose, J., Schlenke, P., Berdel, W. E., Schmidt, T. J., Müller-Tidow, C., Frampton, J., & Klempnauer, K.-H. (2016). Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction. Blood, 127(9), 1173–1182. https://doi.org/10.1182/blood-2015-09-668632

Chicago

Uttarkar, Sagar, Emilie Dassé, Anna Coulibaly, Simone Steinmann, Anke Jakobs, Caroline Schomburg, Amke Trentmann, et al. 2016. “Targeting Acute Myeloid Leukemia with a Small Molecule Inhibitor of the Myb/P300 Interaction.” Blood 127 (9): 1173–82. doi:10.1182/blood-2015-09-668632.